Literature DB >> 10451448

Low-dose difluoromethylornithine and polyamine levels in human prostate tissue.

E M Messing1, R R Love, K D Tutsch, A K Verma, J Douglas, M Pomplun, R Simsiman, G Wilding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10451448     DOI： 10.1093/jnci/91.16.1416

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

Authors:  Howard H Bailey; KyungMann Kim; Ajit K Verma; Karen Sielaff; Paul O Larson; Stephen Snow; Theresa Lenaghan; Jaye L Viner; Jeff Douglas; Nancy E Dreckschmidt; Mary Hamielec; Marcy Pomplun; Harry H Sharata; David Puchalsky; Eric R Berg; Thomas C Havighurst; Paul P Carbone
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

3.  Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.

Authors:  Dipak S Pisal; Venkata K Yellepeddi; Ajay Kumar; Radhey S Kaushik; Michael B Hildreth; Xiangming Guan; Srinath Palakurthi
Journal:  Int J Pharm       Date:  2007-08-26       Impact factor: 5.875

4.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.